For the Inventor, By the Inventor

Enter assignee name

Emeryville, CA, United States of America

Cetus Oncology Corporation

USPTO Granted Patents = 28

Forward Citations = 1,156

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Danute E Nitecki (6 out of 31 patents)

Peter Ralph (4 out of 29 patents)

Robert F Halenbeck (4 out of 40 patents)

4. Michael Kriegler (4 out of 21 patents)

5. Kirston E Koths (3 out of 44 patents)

6. David B Ring (2 out of 33 patents)

7. Mazie Yee Coyne (2 out of 10 patents)

8. Ernest S Kawasaki (2 out of 14 patents)

9. George A Martin (2 out of 27 patents)

10. Martha B Ladner (2 out of 14 patents)

11. Arthur E Frankel (2 out of 9 patents)

12. Margaret Moreland (2 out of 17 patents)

13. Robert Zimmerman (2 out of 12 patents)

14. Hing C Wong (1 out of 111 patents)

15. Ian J Mohr (1 out of 13 patents)

Core Competencies:

Monoclonal Antibodies

Cytokine Inhibitors

Interleukin-6

Colony Stimulating Factor-1

Tumor Necrosis Factor

Vaccine Adjuvants

Wound Healing

Papillomavirus

Cancer Therapeutics

Protein Conjugation

Antibody Generation

28 patents: Sort by Forward Citations

1. 6238891 - Method of increasing product expression through solute stress (2001-05-29),

2. 5639593 - Method for determining TNF (1997-06-17),

3. 5629197 - Monoclonal anti-human breast cancer antibodies (1997-05-13),

4. 5591827 - Interleukin-6 receptor antagonists (1997-01-07),

5. 5573930 - DNA encoding various forms of colony stimulating factor-1 (1996-11-12),

6. 5556620 - Use of recombinant colony stimulating factor-1 to enhance wound healing (1996-09-17),

7. 5545518 - Assay for determinig TNF or IL-1 convertase activity (1996-08-13),

8. 5538868 - Recombinant ricin toxin fragments (1996-07-23),

9. 5508031 - Method for treating biological damage using a free-radial scavenger and (1996-04-16),

10. 5503841 - Human IL-2 as a vaccine adjuvant (1996-04-02),

11. 5491065 - Monoclonal antibodies that bind to and neutralize dimeric but not (1996-02-13),

12. 5470569 - Recombinant colony stimulating factor-1 (1995-11-28),

13. 5464936 - Compositions for identification of papillomavirus replication inhibitors (1995-11-07),

14. 5455330 - Interleukin-1 antagonist and uses thereof (1995-10-03),

15. 5425940 - Combination therapy using interleukin-2 and tumor necrosis factor (1995-06-20),

Cetus Oncology Corporation, based in Emeryville, California, is dedicated to advancing cancer treatment through innovative therapeutic solutions. The company specializes in the development of targeted therapies and biologics, focusing on harnessing the immune system to combat various forms of cancer. With a commitment to research and collaboration, Cetus Oncology aims to transform the landscape of oncology by delivering effective and personalized treatment options that address unmet medical needs in the fight against cancer.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

28 Patents

#21 in Emeryville, CA

#2,846 in California

#12,009 in US

#23,262 in the World

Emeryville, CA, United States of America

Cetus Oncology Corporation

Forward Citations = 1,156

54 inventors:

Danute E Nitecki (6 out of 31 patents)

Peter Ralph (4 out of 29 patents)

Robert F Halenbeck (4 out of 40 patents)

4. Michael Kriegler (4 out of 21 patents)

5. Kirston E Koths (3 out of 44 patents)

Please report any incorrect information to [email protected]

Loading…